15 January
On
In Press Releases
Tagged , , , , , , , , ,

New study from Voy shows that patients taking a GLP-1 drug who engaged with coaching sessions and app-based support over the course of 12 months achieved a 30% higher relative body weight loss compared to those using medication alone. (London, January 15, 2026) Voy, the digital health provider, has announced the publication of a new study in the Journal of Medical Internet Research analyzing the efficacy of a GLP-1 drug for achieving weight loss results in patients who engage regularly with a supporting coaching program compared to patients who rely on the medication alone. The large-scale study examined the progress of over 126,000 UK-based Voy patientsRead More →

03 February
On
In Press Releases
Tagged , , , , , ,

Source: Pexels Copyright: Jens Mahnke URL: https://www.pexels.com/photo/person-in-black-sneakers-walking-on-street-1153838/ License: Licensed by JMIR Peripheral artery disease, a painful condition affecting older adults, is caused by a buildup of plaque in the blood vessels of the arms and legs that restricts circulation. Smoking, diabetes, obesity and high cholesterol are contributing factors. Claudication, the cramping pain patients experience in their extremities, affects their quality of life. “It’s really poor leg circulation,” says Tracie Collins, MD, MPH, dean of The University of New Mexico (UNM) College of Population Health. “It compromises your ability to walk.” Medications can help alleviate the symptoms, but taking regular walks is the most effective wayRead More →